These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1360232)

  • 1. Anti-p185HER2 monoclonal antibodies: biological properties and potential for immunotherapy.
    Park JW; Stagg R; Lewis GD; Carter P; Maneval D; Slamon DJ; Jaffe H; Shepard HM
    Cancer Treat Res; 1992; 61():193-211. PubMed ID: 1360232
    [No Abstract]   [Full Text] [Related]  

  • 2. The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer.
    Dean CJ; Allan S; Eccles S; McFarlane C; Styles J; Valeri M; Sandle J; Bakir A; Sacks N
    Year Immunol; 1993; 7():182-92. PubMed ID: 8103950
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor.
    Wels W; Harwerth IM; Mueller M; Groner B; Hynes NE
    Cancer Res; 1992 Nov; 52(22):6310-7. PubMed ID: 1358432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
    De Santes K; Slamon D; Anderson SK; Shepard M; Fendly B; Maneval D; Press O
    Cancer Res; 1992 Apr; 52(7):1916-23. PubMed ID: 1348016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards an immunotherapy for p185HER2 overexpressing tumors.
    Carter P; Rodrigues ML; Lewis GD; Figari I; Shalaby MR
    Adv Exp Med Biol; 1994; 353():83-94. PubMed ID: 7985544
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies.
    Kasprzyk PG; Song SU; Di Fiore PP; King CR
    Cancer Res; 1992 May; 52(10):2771-6. PubMed ID: 1349849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
    Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.
    Shepard HM; Lewis GD; Sarup JC; Fendly BM; Maneval D; Mordenti J; Figari I; Kotts CE; Palladino MA; Ullrich A
    J Clin Immunol; 1991 May; 11(3):117-27. PubMed ID: 1679763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
    Di Fiore PP; Kraus MH
    Cancer Treat Res; 1992; 61():139-60. PubMed ID: 1360229
    [No Abstract]   [Full Text] [Related]  

  • 10. Herceptin: breaking new ground.
    Cohen RL
    Cancer Biother Radiopharm; 1999 Feb; 14(1):1-4. PubMed ID: 10850280
    [No Abstract]   [Full Text] [Related]  

  • 11. Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplification.
    Tagliabue E; Centis F; Campiglio M; Mastroianni A; Martignone S; Pellegrini R; Casalini P; Lanzi C; Ménard S; Colnaghi MI
    Int J Cancer; 1991 Apr; 47(6):933-7. PubMed ID: 1672668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodinated monoclonal antibodies in the imaging and treatment of human renal cell carcinoma xenografts in nude mice.
    Vessella RL; Lange PH; Palme DF; Chiou RK; Elson MK; Wessels BW
    Targeted Diagn Ther; 1988; 1():245-82. PubMed ID: 2979058
    [No Abstract]   [Full Text] [Related]  

  • 13. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
    Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.
    Hudziak RM; Lewis GD; Winget M; Fendly BM; Shepard HM; Ullrich A
    Mol Cell Biol; 1989 Mar; 9(3):1165-72. PubMed ID: 2566907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells.
    Kumar R; Shepard HM; Mendelsohn J
    Mol Cell Biol; 1991 Feb; 11(2):979-86. PubMed ID: 1671297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy of solid tumors: from fairytale to reality.
    Adams GP; Weiner LM
    Cancer Biother Radiopharm; 2001 Feb; 16(1):9-11. PubMed ID: 11279802
    [No Abstract]   [Full Text] [Related]  

  • 17. Humanization of an anti-p185HER2 antibody for human cancer therapy.
    Carter P; Presta L; Gorman CM; Ridgway JB; Henner D; Wong WL; Rowland AM; Kotts C; Carver ME; Shepard HM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4285-9. PubMed ID: 1350088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effects of monoclonal antireceptor antibodies reactive with neu oncogene product, p185neu.
    Myers JN; Drebin JA; Wada T; Greene MI
    Methods Enzymol; 1991; 198():277-90. PubMed ID: 1677444
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.
    Lewis GD; Figari I; Fendly B; Wong WL; Carter P; Gorman C; Shepard HM
    Cancer Immunol Immunother; 1993 Sep; 37(4):255-63. PubMed ID: 8102322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
    Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
    Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.